ABCG2 and neoplasm: Since a high M2/M1 ratio is associated with a more metastatic phenotype in OS [21], targeting of the ABC transporters effluxing cholesterol on immune-infiltrating cells could be a promising strategy to reduce OS progression, facilitating the efficacy of chemotherapy in eradicating the tumor or limiting the metastatic dissemination.